BPI
AUPH icon

BFC Planning, Inc.’s Aurinia Pharmaceuticals AUPH Stock Holding History

BFC Planning, Inc.’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.81K Sell
519
-981
-65% -$15.7K ﹤0.01% 2428
2026
Q1 		$22.2K Sell
1,500
-5
-0.3% -$73 ﹤0.01% 1664
2025
Q4 		$24K Buy
1,505
+1,000
+198% +$14.2K ﹤0.01% 1672
2025
Q3 		$5.58K Buy
505
+500
+10,000% +$5.46K ﹤0.01% 2157
2025
Q2 		$42 Hold
5
– – ﹤0.01% 2641
2025
Q1 		$40 Hold
5
– – ﹤0.01% 2632
2024
Q4 		$45 Buy
+5
New +$41 ﹤0.01% 2566

Other funds holding AUPH

Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

BFC Planning, Inc.'s AUPH Position: Q2 2026 in Review

BFC Planning, Inc. reduced its Aurinia Pharmaceuticals (AUPH) stake by 65% in Q2 2026, selling an estimated $15.7K and leaving 519 shares worth $8.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2428.

BFC Planning, Inc. first reported a position in AUPH in Q4 2024 and has held it in 7 quarters since. The position peaked at $24K in Q4 2025. 285 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • BFC Planning, Inc. held 519 shares of Aurinia Pharmaceuticals worth $8.81K as of Q2 2026.
  • BFC Planning, Inc. sold 981 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $15.7K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2428 holding.
  • BFC Planning, Inc. first reported a position in Aurinia Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Aurinia Pharmaceuticals position peaked at $24K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.